glp-1 cirrhosis Agonists May Lower Cirrhosis, Liver Cancer Risk in Type 2 Diabetes Patients Glucagon-like Peptide-1 Receptor Agonists (GLP-1
Description
March 23, 2026 Key takeaways GLP-1 raises resting heart rate and lowers nighttime HRV
This led to clinical trials for further validation
If tirzepatide proves effective, it might offer an alternative or complementary approach, particularly for individuals who have not responded adequately to standard treatments or who have co-occurring metabolic conditions
)
K.et al (2010)
One limitation of the current study is that only women with a live birth were included
